Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol in Type I Gaucher Disease
NCT01463215Phase 2Suspended
- Sponsor
- ExSAR
- Start
- Dec 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ambroxol hydrochloride oral solution in Gaucher disease type I (GD1), sponsored by ExSAR. Started Dec 2012; status: suspended.
02
Drugs
Ambroxol hydrochloride oral solution
03
Conditions
Gaucher disease type I (GD1)
Beyond the preview
Go deeper on NCT01463215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01463215.